Easywell Biomedicals, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 197.28 million compared to TWD 267.65 million a year ago. Net loss was TWD 150.39 million compared to TWD 173.41 million a year ago.

Basic loss per share from continuing operations was TWD 1.4143 compared to TWD 1.8571 a year ago.